A pulmonary surfactant formulation for instillation and oral application, containing at least 0.1% by weight of 2,3 -dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone in addition to an effective amount of pulmonary surfactant and usual excipients.

Um formulation pulmonary do surfactant para o instillation e a aplicação oral, contendo ao menos 0.1% por um peso de 2.3 - dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone além a uma quantidade eficaz de surfactant pulmonary e de excipients usuais.